News – Page 94 – Endpoints News

J&J trims pipeline, including two mid-stage neuroscience studies

7 months ago

Cycle makes another offer for Vanda; Ocean Biomedical, Molecure ink new deal

7 months ago

MeiraGTx's stock rises on small Parkinson's gene therapy dataset

7 months ago

Walgreens plans to close 1,200 pharmacies

7 months ago

Pfizer partners with molecular glue startup Triana in $49M upfront deal

7 months ago

Tolerance Bio emerges from stealth with $17.2M to advance therapies developed from the thymus

7 months ago

Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex

7 months ago

Exclusive: Biotech tools company raises $75M for protein manufacturing tech

7 months ago

Forbion raises €2.1B for two new biotech funds after series of company exits

7 months ago

Novo Nordisk files 18 lawsuits against GLP-1 compounders in 44 days

7 months ago

Novartis used a PRV to speed Kisqali's latest indication, FDA says

7 months ago

Eli Lilly reveals £279M investment in the UK through new government deal

7 months ago

Bausch + Lomb's stock rises following report of potential bid from private equity firms TPG and Blackstone

7 months ago

Two GSK trials with long-acting drug in chronic rhinosinusitis hit primary endpoints

7 months ago

Pfizer details results from failed Phase 3 trial of Duchenne muscular dystrophy gene therapy

7 months ago

Jasper shares rally as chronic hives drug scores in small, early trial

7 months ago

Akeso raises $250M; SalioGen’s layoffs

7 months ago

How Endpoints covers AI, and a chance to hear from two Nobel winners

7 months ago

Letters to the Editor

Novartis ends mid-stage IPF trial, will keep testing drug in PAH

7 months ago

Mark Pruzanski gets another shot at MASH, joining as chair of Inventiva as it gets ‘much-needed funding’

7 months ago

Updated: Lundbeck makes $2.6B cash move for Longboard a month after starting Phase 3 in Dravet syndrome

7 months ago

Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock

7 months ago

Catalent sells New Jersey plant to Belgian CDMO, plans moving HQ elsewhere

7 months ago

Transgene shares dip as therapeutic cancer vaccine disappoints in Phase 2 trial

7 months ago

First page Previous page 91 92 939495 96 97 Next page Last page